The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety results from phase I/II study of the PI3Kβ inhibitor GSK2636771 (G) in combination with pembrolizumab (P) in patients (pts) with PD-1 refractory metastatic melanoma (MM) and PTEN loss.
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst)
 
Weiyi Peng
No Relationships to Disclose
 
Suzanne Phillips
No Relationships to Disclose
 
Denai R. Milton
No Relationships to Disclose
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Adi Diab
Honoraria - Array BioPharma
Consulting or Advisory Role - Celgene; CureVac; Idera; Nektar
Research Funding - Apexigen; Celgene (Inst); Idera (Inst); Merck; Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Isabella Claudia Glitza
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Lilly
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Cardinal Health; Castle Biosciences
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Clinica Santa Maria
Other Relationship - Immunocore; Reata Pharmaceuticals
 
Michael K.K. Wong
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer; Pfizer/EMD Serono; Regeneron
 
Cassian Yee
Consulting or Advisory Role - Adaptive Biotechnologies; Berkeley Lights; Immatics; Torque
Patents, Royalties, Other Intellectual Property - Invention for discovery of tumor antigen targets and TCR sequences; Invention for use of IL21
 
Jennifer Leigh McQuade
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Merck
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics; NanoString Technologies; Novartis
 
Alexander J. Lazar
Leadership - Archer; Iterion Therapeutics; Nucleai
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Deciphera; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Michael Shephard
No Relationships to Disclose
 
Suzanne Cain
No Relationships to Disclose
 
Elizabeth M. Burton
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - Dragonfly Therapeutics; Immatics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Sanofi
Research Funding - Genentech (Inst)
 
Michael A. Davies
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; NanoString Technologies; Novartis; Sanofi; Syndax; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)